Abbott Laboratories newest continuous glucose monitor is now available at participating retail pharmacies and through durable medical equipment suppliers. The Freestyle Libre 3 was approved by the FDA in June and is a step up from previous Abbott systems. CNBC's Erin Black, a type 1 diabetic, tested out the Libre 3 for over a month. Here is her review. https://cnb.cx/3gaWvHI | CNBC

BREAKING: Our FreeStyle Libre 2 system with optional real-time glucose alarms and excellent accuracy now cleared by the FDA for children (4 years) and adults with diabetes. https://abbo.tt/2Y1pVwn Important safety info: abbo.tt/2Ju7BDg | Abbott

Real-world data from 50,000 #FreeStyle Libre users showed us that the more you scan, the more you know. And the more you know, the better your glucose control. All with one simple swipe. #KnowMoreLiveBetter http://abbott.mediaroom.com/2017-02-15-Real-World-Data-from-Abbotts-FreeStyle-R-Libre-Show-Association-Between-Higher-Frequency-of-Glucose-Monitoring-and-Improved-Glucose-Control-for-People-with-Diabetes | Abbott